Neuland Laboratories Limited has issued a formal communication correcting a typographical error in their previous letter dated February 9, 2026. The original letter mentioned a date of February 9, 2026, which should have been stated as February 9, 2025. The correction confirms that no other disclosures, figures, or information within the original communication are subject to change, ensuring clarity regarding the relevant financial period being referenced.
Formal Notice of Correction
Neuland Laboratories Limited has formally addressed a discrepancy found in a regulatory submission made on February 9, 2026. This current communication serves as a Rectification of typo error concerning the preceding letter that referenced the same date.
Details of the Typographical Error
The company clarifies that the previous press release dated February 9, 2026, contained an error regarding a date. The erroneous date mentioned in the original communication should have read February 9, 2025, instead of February 9, 2026. Management explicitly assures stakeholders that there are no other changes or modifications to the substance or content of the prior disclosures.
Quarterly Performance Highlights (Referenced Period)
While the main purpose of the letter is a correction, the attached supporting document highlights the financial performance ending December 31st, 2025 (9MFY26). Total Income for Q3FY26 stood at ₹401.9 crore, showing a 11.4% YoY growth. However, Profit After Tax saw a significant YoY decline of 60.2%, closing Q3FY26 at ₹101.4 crore compared to ₹127.5 crore in Q3FY25.
Executive Commentary
Management stated that operational expenses are impacting immediate EBITDA margins, though they remain positive about long-term growth driven by an increasing customer base and strategic investments in niche capabilities. Furthermore, the company announced an Q3 FY26 Earnings Call scheduled for Monday, February 9, 2026, at 17:30 hrs. IST.
Source: BSE
